Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NOVN
NOVN logo

NOVN Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

No data

No data

News

Barron's
8.0
02-12Barron's
Seeking Dividends? Explore Opportunities in Europe.
  • U.S. Dividend Seekers: Investors in the U.S. are encouraged to explore European markets for potential dividend opportunities.

  • European Market Appeal: European companies are offering attractive dividend yields, which may be appealing compared to U.S. counterparts.

  • Economic Factors: Factors such as currency fluctuations and economic recovery in Europe are influencing the attractiveness of these investments.

  • Investment Strategy: Diversifying into European dividends could enhance returns for U.S. investors seeking income.

Barron's
2.0
02-06Barron's
Biogen Shares Increase Despite Falling Multiple Sclerosis Revenue and Ongoing Declines
  • Stock Performance: Biogen's stock experienced an increase on Friday despite facing declining sales.
  • Drug Portfolio Issues: The company's drug portfolio showed poor performance in the fourth quarter, contributing to investor concerns.
Barron's
3.0
02-04Barron's
Analysis and Outlook: A New Decline in Software Performance
  • Market Trends: The software market is experiencing a significant selloff, indicating a downturn in investor confidence.

  • Company Focus: Anthropic, a key player in the AI sector, is highlighted amidst the broader market challenges.

Barron's
4.5
02-01Barron's
Key Highlights to Monitor This Week: Jobs Report, Amazon, Disney, Alphabet, Palantir, and More
  • Market Volatility: Last week saw increased volatility in equities, with the S&P 500 ending slightly up and the Nasdaq Composite slightly down after a steady interest rate announcement by the Federal Open Market Committee.

  • Microsoft's Earnings Impact: Microsoft experienced a significant drop of 10% in its stock value, resulting in a loss of $357 billion in market capitalization following a disappointing earnings report.

  • Silver Market Collapse: The silver market faced a dramatic decline, falling 31% in a single day, attributed to the nomination of hawkish Kevin Warsh as the next Fed Chair and a prior 50% increase in value this year.

  • Overall Economic Sentiment: The combination of these events reflects a turbulent economic sentiment, with investors reacting to both corporate earnings and shifts in monetary policy.

Barron's
7.5
01-09Barron's
Johnson & Johnson Reaches Agreement with Trump Administration to Reduce Medication Costs
  • Price Reduction Announcement: Johnson & Johnson will lower the prices of certain medications for U.S. consumers.
  • Business Agreement Context: This move aligns with a broader trend of pharmaceutical companies forming agreements with the Trump administration.
Barron's
9.0
2025-12-09Barron's
Cancer Research Boosts Confidence in These Small Biotech Companies
  • Drug Effectiveness: A leukemia drug from Terns Pharmaceuticals has shown effectiveness that surpassed expectations in early phase trial results.
  • Impact on Stakeholders: The positive trial results have generated optimism among doctors and investors regarding the drug's potential.
Wall Street analysts forecast NOVN stock price to rise
0 Analyst Rating
Wall Street analysts forecast NOVN stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for (NOVN) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding NOVN

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (NOVN) stock price today?

The current price of NOVN is 0 USD — it has increased 0

What is (NOVN)'s business?

What is the price predicton of NOVN Stock?

Wall Street analysts forecast NOVN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NOVN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (NOVN)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (NOVN)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (NOVN). have?

(NOVN) has 0 emplpoyees as of April 04 2026.

What is (NOVN) market cap?

Today NOVN has the market capitalization of 0.00 USD.